Ziyuglycoside II

Modify Date: 2025-08-25 19:03:28

Ziyuglycoside II Structure
Ziyuglycoside II structure
Common Name Ziyuglycoside II
CAS Number 35286-59-0 Molecular Weight 604.814
Density 1.3±0.1 g/cm3 Boiling Point 716.2±60.0 °C at 760 mmHg
Molecular Formula C35H56O8 Melting Point 260-263℃
MSDS N/A Flash Point 218.6±26.4 °C

 Use of Ziyuglycoside II


Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1].

 Names

Name (3β)-3-(α-L-Arabinopyranosyloxy)-19-hydroxyurs-12-en-28-oic acid
Synonym More Synonyms

 Ziyuglycoside II Biological Activity

Description Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1].
Related Catalog
In Vitro Ziyuglycoside II (10-60 μM; 24 h and 48 h) inhibits MDA-MB-435 cells growth in a dose-dependent manner. The IC50 of Ziyuglycoside II at 24 h and 48 h is 5.92 μM and 4.74 μM, respectively[1]. Ziyuglycoside II (5-25 μM) induces G0/G1 and S phase arrest in MDA-MB-435 cells at 24 h[1]. Ziyuglycoside II (5-25 μM; 24 hours) significantly increases apoptotic rate of MDA-MB-435 cells[1]. Ziyuglycoside II (5-25 μM; 24 hours) increases expressions of both p53 and p21 in MDA-MB-435 cells, which effect is dose-dependent[1]. Cell Viability Assay[1] Cell Line: MDA-MB-435 cells Concentration: 10, 20, 30, 40, 50, 60 μM Incubation Time: 24 hours and 48 hours Result: The IC50 at 24 h and 48 h was 5.92 μM and 4.74 μM, respectively. Cell Cycle Analysis[1] Cell Line: MDA-MB-435 cells Concentration: 5, 10, 25 μM Incubation Time: 24 hours Result: Induced G0/G1 and S phase arrest. Apoptosis Analysis[1] Cell Line: MDA-MB-435 cells Concentration: 5, 10, 25 μM Incubation Time: 24 hours Result: The apoptotic rate was significantly increased in comparison to that of the control. Western Blot Analysis[1] Cell Line: MDA-MB-435 cells Concentration: 5, 10, 25 μM Incubation Time: 24 hours Result: Treatment resulted in increased expressions of both p53 and p21.
References

[1]. Zhu X, et al. Ziyuglycoside II inhibits the growth of human breast carcinoma MDA-MB-435 cells via cell cycle arrest and induction of apoptosis through the mitochondria dependent pathway. Int J Mol Sci. 2013 Sep 3;14(9):18041-55.

[2]. Zhu X, et al. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells. Toxicol Lett. 2014 May 16;227(1):65-73.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 716.2±60.0 °C at 760 mmHg
Melting Point 260-263℃
Molecular Formula C35H56O8
Molecular Weight 604.814
Flash Point 218.6±26.4 °C
Exact Mass 604.397522
PSA 136.68000
LogP 7.68
Vapour Pressure 0.0±5.2 mmHg at 25°C
Index of Refraction 1.588
Storage condition 2-8°C

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

Urs-12-en-28-oic acid, 3-(α-L-arabinopyranosyloxy)-19-hydroxy-, (3β)-
zirconyl carbonate
(3β)-3-(α-L-Arabinopyranosyloxy)-19-hydroxyurs-12-en-28-oic acid
Ziyuglycoside II
Zirconium carbonate oxide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here






Get all suppliers and price by the below link:

Ziyuglycoside II suppliers

Ziyuglycoside II price

Related Compounds: More...
lead(ii) tartrate
815-84-9
cobalt(II)(glycinate)(1+)
100293-84-3
Urotensin II-Related Peptide (human, mouse, rat) trifluoroacetate salt
342878-90-4
indium(ii) chloride
13465-11-7
lead(II) carbonate
790616-79-4
Crocin II
55750-84-0
paromomycin II
51795-47-2
Copper(II) citrate
17263-57-9
copper(II) propionate monohydrate
21058-13-9
1-(2-(1H-pyrazol-1-yl)ethyl)-4-((5-fluoro-2-methoxyphenyl)sulfonyl)-1,4-diazepane hydrochloride
1396636-81-9
1-(2-(1H-pyrazol-1-yl)ethyl)-4-((3-chloro-2-methylphenyl)sulfonyl)-1,4-diazepane hydrochloride
1396807-80-9
1-(2-(1H-pyrazol-1-yl)ethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-1,4-diazepane hydrochloride
1396748-29-0
(4-((1H-imidazol-1-yl)methyl)phenyl)(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)methanone hydrochloride
1396874-61-5
1-(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)-2-(1-methyl-1H-indol-3-yl)ethanone hydrochloride
1396790-88-7
N-(4-(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepane-1-carbonyl)phenyl)acetamide hydrochloride
1396879-53-0
(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)(o-tolyl)methanone hydrochloride
1396854-58-2
(4-(tert-butyl)phenyl)(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)methanone hydrochloride
1396862-42-2
(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)(3-(trifluoromethyl)phenyl)methanone hydrochloride
1396680-50-4
1-(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl)-1,4-diazepan-1-yl)-2-(2-methoxyphenoxy)ethanone hydrochloride
1421504-37-1